Indocollirio (Indometacin)

Indometacin blocks cyclooxygenase enzymes (COX‑1 and COX‑2) in ocular tissues, which lowers the production of prostaglandins—key mediators of inflammation and pain. By reducing prostaglandin levels at the site of instillation, the drug diminishes cellular inflammation and provides analgesic relief within the eye.

The dosing regimen for Indocollirio is determined by the prescribing eye‑care professional based on the specific condition, severity and patient response. Typical regimens involve one to several drops per eye at prescribed intervals, but the exact dose and duration must be individualized by the clinician.

Safety of indometacin eye drops during pregnancy or lactation has not been definitively established. Use is generally reserved for situations where the potential benefit outweighs any possible risk, and only after a thorough evaluation by a qualified health‑care provider.

To order Indocollirio, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Indocollirio delivers indometacin, a potent NSAID with strong COX inhibition, offering rapid anti‑inflammatory and analgesic effects. Compared with corticosteroid eye drops, it has a lower risk of intra‑ocular pressure rise but may cause local irritation. Relative to other NSAID eye drops, its efficacy is comparable, though individual tolerability can vary.

Indocollirio should be stored at room temperature, preferably below 25 °C, in its original container. Protect the product from direct light and moisture. Keep the bottle tightly closed when not in use and avoid freezing. Do not use if the solution appears discolored or contains particles.

The medication is administered as eye drops. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a small pocket, and instill the prescribed number of drops without touching the bottle tip to the eye or surrounding structures. Close the eye gently for a few seconds to allow absorption.

Serious risks include corneal epithelial defects or ulceration, severe allergic reactions with swelling and erythema, and a sustained increase in intra‑ocular pressure that could threaten vision. If any of these events occur, the patient should discontinue use immediately and seek prompt ophthalmologic evaluation.

Indocollirio should be avoided in individuals with known hypersensitivity to indometacin or other NSAIDs, active ocular infections, or pre‑existing corneal ulcers. Caution is also advised for patients with uncontrolled glaucoma, recent ocular surgery, or those who are pregnant or breastfeeding unless the benefits clearly outweigh the risks.